Assembly Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Assembly Biosciences Stock Summary

Assembly Biosciences competes with Spero Therapeutics, Achilles Therapeutics, Instil Bio, CytomX Therapeutics, and Nuvation Bio. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus infection in the United States. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Assembly Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 70 people.

Assembly Biosciences Key Financial Ratios

Assembly Biosciences Key Balance Sheet Accounts

Assembly Biosciences Key Income Statement Accounts

Assembly Biosciences Key Cash Accounts

Assembly Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Assembly Biosciences's current stock value. Our valuation model uses many indicators to compare Assembly Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Assembly Biosciences competition to find correlations between indicators driving Assembly Biosciences's intrinsic value. More Info.Assembly Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Assembly Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Assembly Biosciences' earnings, one of the primary drivers of an investment's value.

Assembly Biosciences Systematic Risk

Today, most investors in Assembly Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Assembly Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Assembly Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Assembly Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Assembly Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Assembly Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Assembly Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Assembly Biosciences's daily price indicators and compare them against related drivers.

When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.